Target intelligence / Profile preview

Ribosomal protein L35a pseudogene 32 (RPL35AP32)

Target
RPL35AP32
Molecular classification
Pseudogene, Other
01

Overview

Ribosomal protein L35a pseudogene 32 (RPL35AP32) is a human processed pseudogene related to the functional gene RPL35A, which encodes a 60S ribosomal protein involved in the large subunit of the ribosome[9][10]. Pseudogenes like RPL35AP32 are non-coding genomic segments with high sequence similarity to real genes but generally lack the capacity to code for functioning proteins or exert biological activity. There is no evidence of its participation in ribosome structure, protein synthesis, or any regulatory cell process. RPL35AP32 is not recognized as a therapeutic target, is not associated with pathology, and has no role in drug action or biomarker status[9][10]. Key distinction: - RPL35AP32 is distinct from RPL35A (Ribosomal protein L35a), which is a protein-coding gene relevant to ribosomal function and certain diseases (e.g. Diamond-Blackfan anemia)[3][5]. RPL35AP32 itself is not a functional ribosomal protein and has no direct biomedical or pharmacological relevance. - This target is not suitable for structured database entries intended for drug targets or functional biomolecules.

Other names
RPL35A pseudogene 32Ribosomal protein L35a pseudogene 32
02

Mechanism of action

None

03

Biological functions

None established (as is typical for processed pseudogenes)
04

Disease associations

No known disease association or functional role
05

Safety considerations

None identified (it is non-functional)

Beyond the preview

Go deeper on Ribosomal protein L35a pseudogene 32 (RPL35AP32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L35a pseudogene 32 (RPL35AP32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call